Top Markets
#1 Islamic Coin Islamic Coin +151.97%
#2 龙虾 (Lobster) 龙虾 (Lobster) +60.86%
#3 SODAX SODAX +49.32%
#4 Cortex Cortex +32.75%
#5 DexNet DexNet +23.20%
#6 Pons Pons +22.12%
#7 Akedo Akedo +21.20%
#8 OpenEden OpenEden +19.03%
#9 wojak wojak +14.37%
#10 APEX APEX +13.93%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rank in Stocks #5461
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Share Price
$93.80
Last synced: 2025-04-28
Market Cap
$2.68B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aerovate Therapeutics, Inc. (AVTE)

Category

Healthcare
P/S ratio for Aerovate Therapeutics, Inc. (AVTE)
P/S ratio as of August 2026 TTM: 0.00
According to Aerovate Therapeutics, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2023 the company had a P/S ratio of 0.00.
P/S ratio history for Aerovate Therapeutics, Inc. from 2020 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH